Merit Medical Systems | MMSI - 营业费用



金融业
股票价格
USD
资产
USD 2.72B
现金及等价物
USD 488.08M
销售成本
USD 197.08M
流动资产
USD 1.1B
流动负债
USD 216.87M
债务
USD 821.57M
EBIT
USD 44.16M
EBITDA
USD 97.23M
员工
7.4K
EPS每股收益
USD 0.86
股本和储备
USD 1.63B
销售毛利
USD 184.8M
债务利息支出
USD 6.53M
利息收入
USD 3.9M
贷款资金
USD 735.16M
市值
USD 3.88B
净收入
USD 41M
营业费用
USD 337.72M
营业利润
USD 44.16M
普通股股本
USD 59.66M
PE价格收益
45.2
税前利润
USD 51.06M
销售收入
USD 381.9M
销售和管理费用
USD 110.47M
股票
USD 352.39M
贸易债权人
USD 67.85M
应收帐款人
USD 227M


营业费用 更改 日
3M USD 3.26B 1.66B 2026-03
Abbott USD 9.31B 104M 2026-03
AngioDynamics USD 81.95M 1.68M 2025-09
Anika Therapeutics USD 133.9M 103.93M 2026-03
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Olympus JPY 268.42B 35.37B 2026-03
Pfizer USD 90.1B 77.19B 2026-03
STAAR Surgical USD 76.12M 7.38M 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 268.87B 16.12B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03